Phosphoric Acid

Phosphoric Acid

SCHEMBL10920146

Cc1nc2c(OCc3ccccc3)cccn2c1N.O=P(O)(O)O

nearest known ligand 0.86

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATP4A P20648 6/20 0.86
ATP4B P51164 6/20 0.86
CYP1A2 P05177 2/20 0.58
CYP3A4 P08684 2/20 0.58
CYP2D6 P10635 2/20 0.58
CYP2C9 P11712 2/20 0.58
MEN1 O00255 1/20 0.58
MAPK1 P28482 1/20 0.58
BLM P54132 1/20 0.58
PMP22 Q01453 1/20 0.58
KMT2A Q03164 1/20 0.58
HDAC6 Q9UBN7 1/20 0.58
PSEN1 P49768 10/20 0.52
PSEN2 P49810 10/20 0.52
APH1B Q8WW43 10/20 0.52
NCSTN Q92542 10/20 0.52
APH1A Q96BI3 10/20 0.52
PSENEN Q9NZ42 10/20 0.52
CYP2C19 P33261 1/20 0.46
ALPG P10696 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2191144 0.93 ATP4A (1.00) ATP4AATP4BCYP1A2CYP3A4CYP2D6
SCHEMBL2195617 0.83 ATP4A (0.81) ATP4AATP4BCYP1A2CYP3A4CYP2D6
SCHEMBL2189454 0.82 ATP4A (0.79) ATP4AATP4BCYP1A2CYP3A4CYP2D6
SCHEMBL15609152 0.80 ATP4A (0.68) ATP4AATP4BCYP1A2CYP3A4CYP2D6
SCHEMBL2193469 0.80 ATP4A (0.76) ATP4AATP4BCYP1A2CYP3A4CYP2D6
SCHEMBL11064908 0.80 ATP4A (0.68) ATP4AATP4BCYP1A2CYP3A4CYP2D6
SCHEMBL8816284 0.79 ATP4A (0.74) ATP4AATP4BCYP1A2CYP3A4CYP2D6
SCHEMBL11064126 0.78 ATP4A (0.73) ATP4AATP4BCYP1A2CYP3A4CYP2D6
SCHEMBL14231824 0.78 ATP4A (0.65) ATP4AATP4BCYP1A2CYP3A4CYP2D6
SCHEMBL1813915 0.78 ATP4A (1.00) ATP4AATP4BCYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0068378-B1 NOVEL IMIDAZO(1,2-A)PYRIDINES AND PYRAZINES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SCHERING CORPORATION (US) 1986-03-05 EP disclosed
US-4450164-A ANTIULCER AND ANTISECRETORY AGENTS SCHERING CORPORATION (US) 1984-05-22 US disclosed
EP-0068378-A1 Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them SCHERING CORPORATION (US) 1983-01-05 EP disclosed